Prion Research

Drs. Edward Hoover and Candace Mathiason study the transmission, shedding and detection of the Chronic Wasting Disease prion in deer. Learn more...

Research Programs

Functional Genomics Research at CSU

The Department is home to some of the finest biomedical researchers in the nation, working in highly specialized laboratories. Their research focuses on understanding the pathology, improving the diagnostics, and developing more effective treatments, vaccines and cures for internationally important infectious diseases.

MIP Research in the News

Mycobacteria

Potential new target for tuberculosis treatments

Professor Mary Jackson and her lab have discovered an enzyme that is critical to the survival and replication of the bacterial pathogen that causes tuberculosis. Read the entire Today at Colorado State Article.

Deer

Possible New Test for CWD

MIP researchers are developing and evaluating a more sensitive test for chronic wasting disease – including the potential to test for infection in live animals, animal products and the environment. Learn more...

Herbert Schweizer

Bacterial Suicide and Antibiotic Resistance

MIP researchers have found the organism that causes melioidosis can become resistant to the antibiotic most commonly used to treat it by mutating in a way scientists have never seen before. Learn more...

Research Programs

Department faculty participate in research categorized into the following five programs:

Laboratories

To learn more about the specific research that is happening within some of our faculty laboratories, check out their websites:

Arthropod-borne and Infectious Diseases Laboratory

Clinical Immunology Laboratory

The Geiss Laboratory

Mycobacteria Research Laboratories

Rocky Mountain Regional Center of Excellence

The VandeWoude Laboratory

The Wilusz Laboratory

Recent Grant Awards

Title	PI	Sponsor
Immune Response of Johnes Disease Induced by Mycobacterium Avium Subsp. Paratuberculosis-Specific Lipids	Torsten Eckstein	USDA - NIFA
Efficacy Testing of HIV-Specific Microbicides in Humanized Mice	Ramesh Akkina	NIAID
Liposome-siRNA-Peptide Complexes as Therapy to Cure Prion Diseases in Mouse Models	Mark Zabel	NIH - Neurological Disorders & Stroke
Development of an Alternative Screening Method for Detecting Evidence of Mycobacterium Tuberculosis Infections	John Spencer	ADA Technologies, Inc.
Virulence of MDR-TB strains	Ian Orme	NIAID
Ivermectin for Malaria Control	Brian Foy	NIAID
Arbovirus Midgut Escape Mechanisms	Alexander Franz	Kansas State University
Development and Validation of Point-of-Care-Tests for TB	Delphi Chatterjee	Univ of Utah
Mycobacterium Tuberculosis Lipoarabinomannan In Vivo	Libin Shi	NIAID
The Mycobacterium Tuberculosis Dormancy Program	Anne Lenaerts	Univ of Colorado
In Vitro and In Vivo Compound Testing	Herbert Schweizer	Evolva, Inc.
Modified DNA Aptamer Affinity Reagents for Mtb Biomarker Validation	Delphi Chatterjee	Univ of Colorado
Assessment of Liposomal Drugs Alone and in Combination for TB Efficacy	Anne Lenaerts	Merrimack Pharmaceuticals, Inc.
Identification of Nucleophosmin in Canine Cutaneous Mast Cell Tumors and Clinical Correlations	Jeffrey Wilusz	Ohio Animal Health Foundation
Transgenetic Studies of Prion Disease in Cervids	Glenn Telling	NIH-Neurological Disorders & Stroke
Combinatorial Use of Anti-HIV RNA-based Therapeutics	Ramesh Akkina	City of Hope National Medical Center